生物技术进展2024,Vol.14Issue(3) :399-405.DOI:10.19586/j.2095-2341.2023.0164

巨噬细胞糖脂代谢重编程在非酒精性脂肪肝中的研究进展

Research Progress on Glycolipid Metabolism Reprogramming of Macrophage in Non-alcoholic Fatty Liver Disease

席照青 包明威
生物技术进展2024,Vol.14Issue(3) :399-405.DOI:10.19586/j.2095-2341.2023.0164

巨噬细胞糖脂代谢重编程在非酒精性脂肪肝中的研究进展

Research Progress on Glycolipid Metabolism Reprogramming of Macrophage in Non-alcoholic Fatty Liver Disease

席照青 1包明威1
扫码查看

作者信息

  • 1. 武汉大学人民医院心血管内科,武汉 430060;武汉大学心血管病研究所,武汉 430060;心血管病湖北省重点实验室,武汉 430060
  • 折叠

摘要

非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)是我国最常见的慢性肝病,涉及脂肪变性、炎症、纤维化等多种生理病理过程.肝脏中含有大量巨噬细胞,越来越多的证据表明在非酒精性脂肪肝进展过程中巨噬细胞的糖脂代谢特征发生了显著变化,且调控代谢可以调节巨噬细胞的免疫功能,进而影响肝脏局部的炎症环境及肝细胞的代谢.综述了NAFLD的进展过程中巨噬细胞的糖脂代谢的变化以及参与上述过程的关键分子,以期为NAFLD治疗找到新靶点.

Abstract

Non-alcoholic fatty liver disease(NAFLD)is the most common chronic liver disease in China,involving various pathophysiological processes such as steatosis,inflammation,and fibrosis.The liver contains a large number of macrophages.More and more evidence suggests that the glycolipid metabolism characteristics of macrophages have changed significantly during the progress of non-alcoholic fatty liver disease,and the regulation of metabolism can regulate the immune function of macro-phages,which in turn affects the local inflammatory environment of the liver and the metabolism of hepatocytes.This article re-viewed the changes in glycolipid metabolism of macrophages during the progress of NAFLD and the key molecules involved in the above processes,in order to find new targets for the treatment of NAFLD.

关键词

非酒精性脂肪肝/巨噬细胞/糖脂代谢重编程

Key words

non-alcoholic fatty liver disease/macrophage/glycolipid metabolic reprogramming

引用本文复制引用

基金项目

国家自然科学基金(8177050781970438)

出版年

2024
生物技术进展
中国农业科学院茶叶研究所 中国农业科学院生物科技研究所

生物技术进展

CSTPCD
影响因子:0.554
ISSN:2095-2341
参考文献量56
段落导航相关论文